Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03152162 · ClinicalTrials.gov registry record
A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System
A clinical trial, sponsored by Restor3D.
- Terminated
- Registry status
- 102
- Enrollment target
NCT03152162 is a clinical trial that was terminated before completion, run by Restor3D. The registered enrollment target is 102 participants.
The verdict
NCT03152162 was terminated before completion, sponsored by Restor3D.
- TERMINATED
- Registry status
- 102 participants
- Enrollment target
Study Summary
This is a prospective clinical study designed to observe the long-term clinical outcomes of total knee arthroplasty using a patient-specific, posterior stabilized implant in patients with osteoarthritis.
Interventions
- DEVICE iTotal PS KRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2022-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03152162
The ClinicalTrials.gov registry entry for NCT03152162 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Restor3D, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iTotal PS KRS is the first listed.
NCT03152162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03152162 about?
NCT03152162 is a clinical study titled "A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System". This is a prospective clinical study designed to observe the long-term clinical outcomes of total knee arthroplasty using a patient-specific, posterior stabilized implant in patients with osteoarthritis.
What is the current status of trial NCT03152162?
This trial is currently terminated. The enrollment target is 102 participants. The study started on 2017-05-01. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT03152162?
The interventions under investigation include: iTotal PS KRS (DEVICE).
Who is sponsoring clinical trial NCT03152162?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.